Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126568612 | 12656861 | 2 | F | 20160527 | 20160817 | 20160816 | 20160824 | EXP | CH-SA-2016SA148518 | AVENTIS | 64.00 | YR | A | F | Y | 0.00000 | 20160824 | MD | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126568612 | 12656861 | 1 | PS | AUBAGIO | TERIFLUNOMIDE | 1 | Oral | Y | UNKNOWN | 202992 | |||||||||
| 126568612 | 12656861 | 2 | SS | CEFUROXIME. | CEFUROXIME | 1 | Oral | Y | UNKNOWN | 0 | |||||||||
| 126568612 | 12656861 | 3 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 0 | |||||||||||
| 126568612 | 12656861 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 0 | |||||||||||
| 126568612 | 12656861 | 5 | C | ASPIRIN CARDIO | ASPIRIN | 1 | Oral | 0 | |||||||||||
| 126568612 | 12656861 | 6 | C | LERCANIDIPINE | LERCANIDIPINE | 1 | Oral | 0 | |||||||||||
| 126568612 | 12656861 | 7 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 0 | ||||||||||||
| 126568612 | 12656861 | 8 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 0 | ||||||||||||
| 126568612 | 12656861 | 9 | C | LISTRIL | LISINOPRIL | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126568612 | 12656861 | 1 | Multiple sclerosis |
| 126568612 | 12656861 | 2 | Bronchitis |
| 126568612 | 12656861 | 3 | Abdominal pain upper |
| 126568612 | 12656861 | 4 | Hypercholesterolaemia |
| 126568612 | 12656861 | 5 | Prophylaxis |
| 126568612 | 12656861 | 6 | Hypertension |
| 126568612 | 12656861 | 7 | Chronic obstructive pulmonary disease |
| 126568612 | 12656861 | 8 | Chronic obstructive pulmonary disease |
| 126568612 | 12656861 | 9 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126568612 | 12656861 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126568612 | 12656861 | Angioedema | |
| 126568612 | 12656861 | Psoriasis | |
| 126568612 | 12656861 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126568612 | 12656861 | 1 | 201509 | 0 | ||
| 126568612 | 12656861 | 2 | 20160520 | 20160526 | 0 | |
| 126568612 | 12656861 | 4 | 201507 | 0 | ||
| 126568612 | 12656861 | 5 | 201507 | 0 |